Arkema S.A. stock (FR0010313833): Q1 slowdown, M&A talks and strategy under investor scrutiny

French specialty chemicals group Arkema S.A. has reported softer Q1 2025 results and is reportedly exploring a potential takeover of Westlake, putting its transformation strategy and exposure to global demand cycles back in focus for international and US investors.

Arkema S.A. has moved back into the spotlight after reporting lower first-quarter 2025 earnings in May and being named in media reports as a potential takeover target for US-based Westlake, highlighting both cyclical headwinds and continuing portfolio reshaping according to an earnings release and press coverage in early May 2025 and April 2025 respectively, as reported by Arkema as of 05/15/2025 and Reuters as of 04/16/2025.

As of: 19.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Arkema
• Sector/industry: Specialty chemicals and advanced materials
• Headquarters/country: Colombes, France
• Core markets: Europe, North America, Asia for high-performance materials and coatings solutions
• Key revenue drivers: Adhesive solutions, advanced materials, coating solutions, intermediates
• Home exchange/listing venue: Euronext Paris (ticker: AKE)
• Trading currency: EUR

Arkema S.A.: core business model

Arkema positions itself as a global player in specialty chemicals, focusing on high-performance materials, adhesive systems and advanced coatings used in demanding industrial applications, rather than on basic commodity chemicals, according to its corporate profile and strategy overview published in 2024 on the company website, as described by Arkema as of 06/30/2024.

The group’s activities are structured around segments such as Adhesive Solutions, Advanced Materials, Coating Solutions and Intermediates, with a strategic aim to increase the share of high-margin specialty businesses in total sales over time, based on information from its 2023 universal registration document filed in March 2024, according to Arkema as of 03/28/2024.

Arkema serves end markets including construction, automotive, electronics, renewable energy, packaging and consumer goods, which means its revenue is sensitive to industrial production, housing activity and investment cycles across Europe, North America and Asia, as outlined in its 2023 annual results presentation published in February 2024, according to Arkema as of 02/28/2024.

Main revenue and product drivers for Arkema S.A.

According to Arkema’s full-year 2023 results released in February 2024, the group generated annual sales of around EUR 9.5 billion for 2023, with adjusted EBITDA of roughly EUR 1.4 billion for the same period, reflecting the impact of softer demand in several industrial markets compared with the previous year, as stated by Arkema as of 02/28/2024.

Within the portfolio, Advanced Materials and Adhesive Solutions are central to Arkema’s growth strategy, offering higher value-added products such as specialty polymers for lightweighting in cars, materials for batteries and adhesives for construction and packaging, with management highlighting these segments as key drivers during the 2023 results presentation in February 2024, according to Arkema as of 02/28/2024.

Intermediates, which include acrylics and fluorogases, tend to be more cyclical and exposed to swings in global chemical demand and pricing, and Arkema has been gradually reducing their relative weight in the portfolio through divestments and a focus on specialties, a trend emphasized in its long-term strategy update presented in September 2023, as reported by Arkema as of 09/27/2023.

Recent earnings: Q1 2025 under cyclical pressure

In its first-quarter 2025 report released on May 15, 2025, Arkema announced that Q1 2025 sales decreased year-on-year to about EUR 2.1 billion, compared with around EUR 2.3 billion in the prior-year quarter, mainly due to continued weak demand in certain industrial markets and lower selling prices, according to Arkema as of 05/15/2025.

The company reported Q1 2025 adjusted EBITDA of roughly EUR 260 million versus about EUR 300 million in the first quarter of 2024, with management citing destocking effects and persistent softness in construction-related applications, while pointing to resilience in several specialty segments, as described in the same earnings release published on May 15, 2025, by Arkema as of 05/15/2025.

Despite the softer quarter, Arkema confirmed its 2025 guidance of achieving an improvement in adjusted EBITDA versus 2024, assuming a gradual demand recovery in the second half of the year, and reiterated its mid-cycle targets set out at the 2023 strategy update, according to statements in its Q1 2025 presentation published on May 15, 2025, as reported by Arkema as of 05/15/2025.

For US-focused investors, these results provide insight into how a European specialty chemicals player exposed to many US industrial and construction markets is navigating a mixed macro environment, given Arkema’s manufacturing footprint and customer base in North America highlighted in its 2023 registration document published in March 2024, according to Arkema as of 03/28/2024.

M&A speculation: reported Westlake interest

On April 16, 2025, Reuters reported that US chemicals group Westlake was exploring a possible acquisition of Arkema, citing sources familiar with the matter, while noting that no final decision had been taken and that discussions could still collapse, according to Reuters as of 04/16/2025.

The same report indicated that Arkema’s market value and the complexity of combining two diversified chemical portfolios could represent obstacles to a potential transaction, and stressed that there was no certainty that Westlake would proceed with a formal offer, reflecting the early-stage and speculative nature of the situation, as underlined by Reuters as of 04/16/2025.

Following the media coverage, Arkema stated that it regularly reviews strategic options in the best interests of shareholders but did not confirm any specific negotiations, emphasizing its focus on executing the organic growth and portfolio transformation plans presented at previous capital markets days, according to comments referenced in press follow-ups published in mid-April 2025 by European financial media, as summarized by Reuters as of 04/16/2025.

For US investors, a possible cross-border combination between Westlake and Arkema would be notable because it could create a larger integrated chemicals player with an expanded footprint in North America and Europe, although valuation, regulatory approvals and integration risks would likely be key issues if any formal offer emerged, as suggested in the M&A analysis parts of the April 16, 2025 article by Reuters as of 04/16/2025.

Strategy: pivot toward higher-value specialties

Arkema’s medium-term strategy, detailed at its September 2023 capital markets update, centers on lifting the share of specialty businesses to around 85% of group sales by 2030, supported by targeted acquisitions, organic investments in high-growth markets and selective divestments of more cyclical assets, according to Arkema as of 09/27/2023.

The group has also set sustainability-related objectives, such as reducing its greenhouse gas emissions by 46% by 2030 compared with 2019 levels and developing solutions that enable customers to lower their environmental footprint, with these targets outlined in its 2023 climate roadmap update published in March 2024, as indicated by Arkema as of 03/27/2024.

In the US market, Arkema has invested in capacity expansions for specialty materials used in batteries, 3D printing and high-performance coatings, seeking to benefit from reshoring trends and infrastructure spending, according to investment announcements and project updates shared during 2023 and 2024 in its news section, as summarized by Arkema as of 11/30/2024.

Conclusion

Arkema S.A. is navigating a challenging industrial environment with softer Q1 2025 results but remains committed to its strategy of shifting further toward specialty materials and advanced solutions, while simultaneously being the subject of reported but uncertain M&A interest from Westlake, underscoring its strategic value within the chemicals sector and keeping the stock under close watch for international and US investors seeking exposure to global industrial and sustainability-related trends.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.